Docs Who Lift

Join Dr. Brueger, an ophthalmologist and retina specialist, as he dives into age-related macular degeneration (AMD) and its potential links to GLP-1 medications. Discover the types and causes of AMD, including key risk factors like genetics and lifestyle. The fascinating conversation also explores how diabetes and its treatments relate to eye health. Dr. Brueger clarifies misconceptions about vision loss from macular degeneration, making it both informative and engaging.

Menopausal hormonal therapy should not be a blanket recommendation for everyone going through menopauseWeight management in women is influenced by hormonal changes throughout life stages.Retrospective analyses can provide insights but have limitations.The wellness industry often oversimplifies complex medical issues.Hormonal replacement therapy may have subtle benefits for weight management.Confounding factors like SSRIs can complicate weight loss efforts.A holistic approach is essential for managing women's health during menopause.Education and awareness are crucial for women navigating menopause.Future research should focus on randomized controlled trials for better clarity.Understanding individual patient experiences is key to effective treatment.Click here to see her studyClick here to follow Dr. Tchang on XClick here to join Dr. Spencer's clinic Vineyard 

Dr. Grant Tinsley joins the discussion as the body composition expert.Myostatin is a key regulator of muscle growth.Wendy Whippete the most jacked muscled up dogThe concern of GLP-1 receptor agonists and muscle mass loss.Overview of Courage trial looking at semaglutide and trevogrumab and lean mass lossUpcoming Believe trial coming out (bimagrumab and semaglutide)Exercise remains crucial for muscle health and function.MRI data from SURPASS MRI provides new insights into muscle volume changes.The combination of medications may have varying effects on muscle mass.Caution is advised regarding the long-term effects of new drugs.Clinical benefits of medications often outweigh concerns about muscle loss.Future research will explore the synergy between exercise and medication.Other docs who lift podcasts with Dr. Grant:Tirzepatide muscle lossLean mass loss and GLP-1 meds

Kevin Klatt, a nutrition PhD and insightful commentator on dietary guidelines, discusses the pressing issues of nutrition research. He criticizes the MAHA report for lacking actionable policies despite addressing public health concerns. Klatt emphasizes the historical context of nutrition guidelines and the inadequacy of current funding for research. He argues that misinformation and political agendas undermine public trust, calling for more rigorous science to inform policy. Ultimately, he advocates for a shift towards policies prioritizing genuine health outcomes over superficial changes.

Tiffany Moon is an anesthesiologist, associate professor, and former star of The Real Housewives of Dallas, who brings her unique perspective on finding joy and purpose in life. She discusses her journey from reality TV to embracing a life centered around genuine connections. Tiffany emphasizes the importance of work-life integration and how to break free from perfectionism. She also shares insights from the Lead Her Summit, aimed at empowering women, and highlights the significance of gratitude in sustaining happiness and fulfillment.

Discover the battle of weight loss medications with tirzepatide showing superior effectiveness over semaglutide. Unpack the complexities of drug pricing and the critical need for affordable access to treatments for severe obesity. Gender influences on weight loss outcomes are explored, alongside the safety and tolerability of these medications. Long-term studies reveal promising benefits beyond weight loss, including improvements in metabolic health. Get the scoop on future research directions, particularly regarding cardiovascular impacts.

TakeawaysMASH is a significant obesity-related complication.Semaglutide shows promise in treating MASH.Weight loss is crucial for improving liver health.Bariatric surgery remains the most effective treatment.The Essence trial indicates a 63% resolution of NASH.New medications are being developed for obesity treatment.Early intervention is key to preventing severe liver damage.Accessibility of medications is a major concern.Comparative studies are essential for evaluating new treatments.Future treatments may include innovative delivery methods.Chapters00:00 Introduction to MASH and Semaglutide Study04:29 Understanding Metabolic Dysfunction and Its Implications08:02 Essence Trial: Semaglutide's Impact on MASH12:58 Comparative Analysis of New Treatments for MASH17:30 The Future of Obesity Treatment and Drug AccessibilityJoin Vineyard - Dr. Spencer's online clinicSee the study

Drs. Karl and Spencer chat with return guest Dr. Lauren Semple about creatine, protein, cortisol, fasting exercise, and training in women.Follow Dr. Lauren's instagramJoin Dr. Spencer's online clinic

Explore the fascinating effects of tirzepatide on metabolic rates and its surprising links to depression. Discover the real-life implications and psychological risks of GLP-1 medications like semaglutide. Delve into personal stories of overcoming weight loss plateaus through the interplay of mental and physical health. Learn about the costs and accessibility challenges of obesity treatments, and how these affect patients' ability to maintain their health. Join the conversation on modern solutions and the future of diabetes management!

Drs. Karl and Spencer discuss the claim that GLP-1 meds cause more fat cells.Learn about if and how GLP-1 meds increase fat cells and what that means along with other claims about these medicine.Join Dr. Spencer's online clinic that specializes in GLP-1 medicines